Grants and Contracts per year
Grants and Contracts Details
Description
Abnormal vascular smooth muscle cell (SMC) growth and migration contributes to hypertension,
atherosclerosis, and restenosis. SMC function is controlled by complex regulatory mechanisms, which
are governed in part by interactions with the extracellular matrix. Integrins, the predominant receptors for
the extracellular matrix, activate adhesion-dependent signaling pathways and cross-talk with growth
factor and G-protein coupled receptors to influence cellular fUnctions. The objective of this application is
to understand how integrin alphaVbeta3-dependent signaling influences SMC growth and migration. We
observed that wild-type mice treated with an antibody-inhibitor of beta3-integrins, but not
beta3-integrin-deficient (beta3-/-) mice, were protected from the development of intimal hyperplasia and
have found differences in the properties of cultured wild-type and beta3-/- SMCs that may account for our
in vivo observations. Based on our preliminary data, we hypothesize that integrin alphaVbeta3-
dependent intracellular signaling positively and negatively regulates SMC growth and migration thorugh
distinct pathways in stimulated and quiescent SMCs. The proposed studies will utilize genetic,
pharmacologic, and RNA interference techniques to target integrin aiphaVbeta3 in well-characterized
cellular and animal models of SMC function. First, we will identify alphaVbeta3-dependent pathways in
stimulated SMCs. Our preliminary data indicates that aiphaVbeta3 serves as a molecular switch to
regulate Rho Family GTPase and control focal adhesion assembly. We will delineate the mechanism(s)
responsible for GTPase regulation. Second, based on our preliminary data, we have identified a role for
aiphaVbeta3 in downregulation of p38MAPK during cellular quiescence. We will use the p38 MAPK
pathway as a model to understand how alphaVbeta3-dependent pathways contribute to SMC
quiescence. Third, we will delineate the contribution of aiphaVbeta3 to physiologic responses in cultured
vessels and well-established mouse models of arterial injury. These results will provide specific insights
into the function of SMC alpha Vbeta3 in restenosis and atherosclerosis and may have broad implications
for understanding aiphaVbeta3 integrin function in angiogenesis, osteoporosis, and other disorqers.
Status | Finished |
---|---|
Effective start/end date | 8/1/04 → 6/30/10 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Projects
- 1 Finished
-
Integrin Signaling in vascular Cells-R01HL074219 Supplement
Smyth, S.
12/1/06 → 6/30/09
Project: Research project